Pneumococcal Conjugate Vaccine (Prevnar™; PNCRM7): A Review of its Use in the Prevention of Streptococcus pneumoniae Infection

Author： Darkes M.J.M.   Plosker G.L.  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.4, Iss.9, 2002-01, pp. : 609-630

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The 7-valent pneumococcal CRM197 conjugate vaccine [Prevnar] is now included in the UK child immunisation programme

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 497, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The safety of 7-valent pneumococcal conjugate vaccine

By Ghaffar Faryal  

Expert Opinion on Drug Safety, Vol. 4, Iss. 4, 2005-07 ,pp. : 631-636

Informa Healthcare

Access to resources Recommend Favorite

7-Valent pneumococcal conjugate vaccine at upper limit of good value

By  

Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Pneumococcal 7-valent CRM197 vaccine conjugate: Lack of efficacy in pneumococcal meningitis in a child: case report

By  

Reactions Weekly, Vol. 1, Iss. 1269, 2009-01 ,pp. : 28-28

Adis International

Access to resources Recommend Favorite

Diphtheria-Tetanus-Acellular Pertussis Vaccine Adsorbed (Triacelluvax™; DTaP3-CB): A Review of its Use in the Prevention of Bordetella pertussis Infection

By Matheson A.J.   Goa K.L.  

Pediatric Drugs, Vol. 2, Iss. 2, 2000-03 ,pp. : 139-159

Adis International

Access to resources Recommend Favorite